Long-term complete remission after severe pembrolizumab-induced immune-related encephalitis in metastatic lung adeno-squamous carcinoma: A case report

Long-term complete remission after severe pembrolizumab-induced immune-related encephalitis in metastatic lung adeno-squamous carcinoma: A case report

Immune checkpoint inhibitors became the treatment of choice, in monotherapy or in association with platinum-based doublet chemotherapy, in first-line therapy for advanced-stage non-small-cell lung cancer without oncogenic driver. Nevertheless, it can be associated with diverse immune-related adverse...

Full description

Bibliographic Details
Main Authors:	Rémy Quirynen, Sebahat Ocak, Fabrice Duplaquet, Lionel Pirard
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Respiratory Medicine Case Reports
Subjects:	Non-small-cell lung cancer Immune checkpoint inhibitor Immune-mediated neurological adverse event Complete remission
Online Access:	http://www.sciencedirect.com/science/article/pii/S221300712300093X

Similar Items

Complete remission in a patient with metastatic gastric cancer receiving tislelizumab combined with chemotherapy: a case report
by: Zhe Zhu, et al.
Published: (2023-05-01)

Case Report: Complete Remission of a Patient With Metastatic Gastric Cancer Treated With Nivolumab Combined With Chemotherapy After Palliative Surgery
by: Peilin Dai, et al.
Published: (2022-06-01)

Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports
by: Kazuki Gohara, et al.
Published: (2021-01-01)

Successful treatment with nivolumab in a patient with unresectable oral squamous cell carcinoma following ineffective chemoradiotherapy
by: Katsuhisa Sekido, et al.
Published: (2023-12-01)

Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
by: Cédric Mahiat, et al.
Published: (2023-02-01)

Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
by: Frederik Uttenthal Larsen, MD, et al.
Published: (2019-06-01)

Complete remission of gallbladder neuroendocrine carcinoma with liver metastasis by tislelizumab plus chemotherapy: a case report
by: Huafei Li, et al.
Published: (2024-01-01)

Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
by: Nobutaka Nishimura, et al.
Published: (2022-09-01)

Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
by: Katsuhisa Sekido, et al.
Published: (2021-09-01)

Case report: Spontaneous remission in lung carcinoma with a late relapse after adjuvant immunotherapy: Exceptional tumor micro-environment
by: Yan Chen, et al.
Published: (2023-02-01)

Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature
by: R. Saad, et al.
Published: (2024-02-01)

Evaluation of angiopoietin-2 level in patients with multiple myeloma at presentation and in remission state
by: Zahraa Mudher M Salih, et al.
Published: (2023-01-01)

A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study
by: Swiss Medical Weekly
Published: (2006-02-01)

Spontaneous complete remission of type 1 diabetes mellitus in an adult – review and case report
by: Harsha Moole, et al.
Published: (2015-10-01)

Spontaneous remission of a “diffuse glioma” – A case report
by: Maximilian Scheer, et al.
Published: (2022-06-01)

Comparative clinical outcomes after thymectomy for myasthenia gravis: Thoracoscopic versus trans-sternal approach
by: Sophon Siwachat, et al.
Published: (2018-01-01)

Regression of cutaneous squamous cell carcinoma after the development of pembrolizumab‐induced bullous pemphigoid
by: Shin Iinuma, et al.
Published: (2023-03-01)

Early development of pembrolizumab‐induced fulminant myositis and cardiotoxicity in a patient with metastatic thymoma
by: Soo Yeon Jang, et al.
Published: (2022-09-01)

Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma
by: Nikolaos Spathas, et al.
Published: (2018-09-01)

Long-lasting complete remission in a patient with systemic metastases of recurrent breast cancer treated with cyclin-dependent kinases 4/6 inhibitors: a case report
by: Toshihiko Yoneto, et al.
Published: (2023-05-01)

Does surgical treatment within 4 hours after trauma have an influence on neurological remission in patients with acute spinal cord injury?
by: Biglari B, et al.
Published: (2016-08-01)

Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab
by: Naoki Kadota, et al.
Published: (2022-08-01)

ASSOCIATION OF HYPERDIPLOIDY WITH REMISSION STATUS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AFTER INDUCTION THERAPY
by: Saqib Hussain Korejo, et al.
Published: (2019-06-01)

Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan
by: Motohiro Fujiwara, et al.
Published: (2021-12-01)

Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC)
by: Bo Peng, et al.
Published: (2017-05-01)

Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy
by: Pei-Hung Chang, et al.
Published: (2024-02-01)

Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma
by: Inokuchi J, et al.
Published: (2019-05-01)

Complete Remission of Acute Myeloid Leukemia in Induction and Consolidation Chemotherapy without Bone Marrow Transplantation: Lessons Learned from Good Presentation Case
by: Tuti Sri Hastuti, et al.
Published: (2019-03-01)

Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report
by: Maria Anna Siciliano, et al.
Published: (2020-10-01)

A case of panuveitis and retinal vasculitis associated with pembrolizumab therapy for metastatic lung cancer
by: Kyung Woo Kim, et al.
Published: (2021-06-01)

Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies
by: Aurélie Delannoy, et al.
Published: (2019-03-01)

Pembrolizumab‐induced pancytopenia in a patient with squamous cell lung cancer
by: Yuriko Ueki, et al.
Published: (2020-09-01)

Complete response to pembrolizumab for metastatic urothelial carcinoma in the renal pelvis of allograft kidney
by: Jun Kamei, et al.
Published: (2022-05-01)

Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab
by: Salma Charabi, et al.
Published: (2021-04-01)

Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients’ Outcomes?
by: Jonathan Thouvenin, et al.
Published: (2023-01-01)

Complete remission of Hodgkin Lymphoma after a concurrent infection with COVID-19: systematic review and meta-analysis
by: Nasser ghaly yousif
Published: (2022-09-01)

The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy
by: Suyan Duan, et al.
Published: (2023-12-01)

Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports
by: Stefan Schliep, et al.
Published: (2018-01-01)

Case Report: Pathological Complete Response in a Brain-Metastatic Lung Squamous Cell Carcinoma Patient With Long-Term Benefit From Chemo-Immunotherapy
by: Chen Hu, et al.
Published: (2021-09-01)

Objective Responses in Metastatic Pleomorphic Rhabdomyosarcoma Treated with Combination of Doxorubicin and Pembrolizumab: A Case Series
by: Ioannis Kournoutas, et al.
Published: (2024-02-01)